Literature DB >> 20881213

Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.

Klaus Romero1, Brian Corrigan, Christoffer W Tornoe, Jogarao V Gobburu, Meindert Danhof, William R Gillespie, Marc R Gastonguay, Bernd Meibohm, Hartmut Derendorf.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20881213     DOI： 10.1177/0091270010377788

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  8 in total

Review 1.  Reproducible pharmacokinetics.

Authors:  John P A Ioannidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-19       Impact factor: 2.745

2.  Data standards for model-informed drug development: an ISoP initiative.

Authors:  Andrijana Radivojevic; Brian Corrigan; Nicholas Downie; Robert Fox; Jill Fiedler-Kelly; Huan Liu; Murad Melhem; David Radke; Peter Schaefer; Jing Su; Maciej J Swat; Nathan S Teuscher; Neelima Thanneer; Alice Zong; Justin J Wilkins
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-07-25       Impact factor: 2.745

Review 3.  Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflow.

Authors:  Henning Schmidt; Andrijana Radivojevic
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-07-24       Impact factor: 2.745

4.  Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.

Authors:  Daniela J Conrado; Jane Larkindale; Alexander Berg; Micki Hill; Jackson Burton; Keith R Abrams; Richard T Abresch; Abby Bronson; Douglass Chapman; Michael Crowther; Tina Duong; Heather Gordish-Dressman; Lutz Harnisch; Erik Henricson; Sarah Kim; Craig M McDonald; Stephan Schmidt; Camille Vong; Xiaoxing Wang; Brenda L Wong; Florence Yong; Klaus Romero
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-05-24       Impact factor: 2.745

Review 5.  Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.

Authors:  Ashit Trivedi; Richard E Lee; Bernd Meibohm
Journal:  Expert Rev Clin Pharmacol       Date:  2013-03       Impact factor: 5.045

6.  Reporting guidelines for population pharmacokinetic analyses.

Authors:  Kevin Dykstra; Nitin Mehrotra; Christoffer Wenzel Tornøe; Helen Kastrissios; Bela Patel; Nidal Al-Huniti; Pravin Jadhav; Yaning Wang; Wonkyung Byon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-04-30       Impact factor: 2.745

7.  Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.

Authors:  Lina Keutzer; Huifang You; Ali Farnoud; Joakim Nyberg; Sebastian G Wicha; Gareth Maher-Edwards; Georgios Vlasakakis; Gita Khalili Moghaddam; Elin M Svensson; Michael P Menden; Ulrika S H Simonsson
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

8.  Communicating to Influence Drug Development and Regulatory Decisions: A Tutorial.

Authors:  S Mehrotra; J Gobburu
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.